Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 3, 1996, Pages 311-315

  Seiler, Nikolaus ^a   Delcros, Jean Guy ^a   Cipolla, Bernard ^a   Chamaillard, Laura ^a   Havouis, René ^a   Quemener, Véronique ^a   Moulinoux, Jacques Philippe ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

2 (4 aminoiminomethyl) 2,3 dihydro 1H inden 1 ylidene dihydrochloride; CAS 149400 88 4; CGP 48664A, pharmacology; prostatic adenocarcinoma; S adenosylmethionine decarboxylase, inhibitor

Indexed keywords

4 AMIDINO 1 INDANONE 2' AMIDINOHYDRAZONE; MITOGUAZONE; N,N' BIS(2,3 BUTADIENYL)PUTRESCINE; POLYAMINE; POLYAMINE OXIDASE; S ADENOSYLMETHIONINE DECARBOXYLASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; DRUG ACCUMULATION; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; POLYAMINE METABOLISM; PROSTATE ADENOCARCINOMA; RAT; TUMOR GROWTH; TUMOR VASCULARIZATION; XENOGRAFT;

ADENOCARCINOMA; ADENOSYLMETHIONINE DECARBOXYLASE; AMIDINES; ANIMALS; ANTINEOPLASTIC AGENTS; BIOGENIC POLYAMINES; BODY WEIGHT; ENZYME INHIBITORS; INDANS; LIVER; LUNG NEOPLASMS; MACROPHAGES, PERITONEAL; MALE; NEOPLASM TRANSPLANTATION; ORGAN SIZE; PHAGOCYTOSIS; PROSTATIC NEOPLASMS; RATS; RATS, INBRED STRAINS;

EID: 0030007124     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Atanassov, C. L., Muller, C. D., Sarhan, S. et al., Res. Immunol. 145, 277 (1994)
2. Bolkenius, F. N., Seiler, N., Biochim. Biophys. Acta 923, 125 (1987)
3. Bowlin, T. L., Hoeper, B. J., Rosenberger, A. L. et al., Cancer Res. 50, 4510 (1990)
4. Chamaillard, L., Quemener, V., Havouis, R. et al., Anticancer Res. 13, 1027 (1993)
5. Claverie, N., Wagner, J., Knödgen, B. et al., N. Anticancer Res. 7, 765 (1987)
6. Danzin, C., Marchal, P., Casara, P., Biochem. Pharmacol. 40, 1499 (1990)
7. Fidler, J., Int. J. Oncol. 6, 293 (1995)
8. Flescher, E., Bowlin, T. L., Talal, N., J. Immunol. 142, 907 (1989)
9. Hölttä, E., Biochemistry 16, 91 (1977)
10. Moulinoux, J.-Ph., Quemener, V., Cipolla, B. et al., N. J. Urol. 146, 1409 (1991)
11. Regenass, U., Mett, H., Stanek, J. et al., Cancer Res. 54, 3210 (1994)
12. Sarhan, S., Dezeure, F., Seiler, N., Int. J. Biochem. 19, 1037 (1987)
13. Sarhan, S., Knödgen, B., Seiler, A., Anticancer Res. 9, 215 (1989)
14. Sarhan, S., Quemener, V., Moulinoux, J. Ph. et al., Int. J. Biochem. 23, 617 (1991)
15. Sarhan, S., Knödgen. B., Seiler, N., Anticancer Res. 12, 457 (1992)
16. Seiler, N., Atanassov, C. L., Progr. Drug Res. 43, 87 (1994)
17. Seiler, N., Knödgen, B. J., Chromatogr. 221, 227 (1980)
18. Seiler, N., Bolkenius, F. N., Knödgen, B. et al., Biochim. Biophys. Acta 615, 480 (1980)
19. Seiler, N., Sarhan, S., Grauffel, C. et al., Cancer Res. 50, 5077 (1990)
20. Seiler, N., Sarhan, S., Mamont, P. et al., Life Chem. Rep. 9, 151 (1991)
21. Ware, J. L., Biochim. Biophys. Acta 907, 279 (1987)
22. Williams-Ashman, H. G., Pegg, A. E., in: Polyamines in Biology and Medicine, D. R. Morris, L. J. Marton (eds.), p. 43, Marcel Decker, New York (1981)